OVERPHARMA, LDA. secures contract for Acquisition Of Metronidazole, Iv, 5Mg/Ml; 100Ml, Sol Injp, Under Cpa 2023/492, For Ulsasi, For The Year 2025

Portugal, Aug. 12 -- Portugal based OVERPHARMA, LDA. has secured contract from Unidade Local De Saude Amadora/Sintra, E.P.E. for Acquisition Of Metronidazole, Iv, 5Mg/Ml; 100Ml, Sol Injp, Under Cpa 2023/492, For Ulsasi, For The Year 2025. The value of the contract is worth 360000 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....